7G Bioventures
Overview
7G BioVentures is a venture capital firm that focuses on investing in first-in-class life science innovations across the United States, Canada, and Europe. The firm aims to support scientists, clinicians, and entrepreneurs in translating breakthrough discoveries into life-saving products.
Portfolio Companies
5
Website
7gventures.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| i2O Therapeutics | Aug 2023 | Series A | Co-investor |
| Optimeos Life Sciences | Aug 2023 | Seed | Lead |
| BBy, Inc. | May 2023 | Seed | Co-investor |
| Curbside Health | Jan 2022 | Seed | Co-investor |
| Kayothera | Mar 2022 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is 7G Bioventures based?
7G Bioventures is headquartered in Burlingame, California, United States.
When was 7G Bioventures founded?
Founding year information for 7G Bioventures is not publicly available.
How many portfolio companies does 7G Bioventures have?
7G Bioventures has 5 portfolio companies in Caplight's dataset.
What are some companies in 7G Bioventures's portfolio?
Portfolio companies visible on Caplight include i2O Therapeutics, Optimeos Life Sciences, BBy, Inc., Curbside Health, Kayothera.
What was 7G Bioventures's most recent investment shown here?
7G Bioventures's most recent investment in this portfolio sample was in i2O Therapeutics in 2023.
What sectors does 7G Bioventures focus on?
7G Bioventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software.
What company stages does 7G Bioventures focus on?
7G Bioventures typically invests at the Early stage.